ADHD medicalization in Argentina. Reflections on global trends and local specificities through the study of methylphenidate and atomoxetine
DOI:
https://doi.org/10.5007/2175-7984.2020.e74324Abstract
The general objective is to contribute to a panoramic view of the phenomenon of the medicalization
of ADHD in Argentina, and to discussions about the dissemination of knowledge about childhood. The analysis is part of studies on the transformation and expansion of medicalization in the XXI century, and the processes of diagnosis and treatment of ADHD are addressed. The article presents data from 1) world production and consumption of methylphenidate, and data from
Argentina from 2) import of methylphenidate as monodrug (2003-2016); 3) dispensed containers
of atomoxetine and methylphenidate (2005-2010 and 2012-2016). These data are triangulated with qualitative sources: 84 semi-structured interviews, individual and group, between 2007 and 2017, to health professionals with clinical, teaching and research activities in the City of Buenos
Aires, Tierra del Fuego, Corrientes and Salta. Consonant and dissonant Argentine trends with these processes are described and analyzed worldwide.
References
ABRAHAM, J. Pharmaceuticalization of society in context: Theoretical, empirical and HealthDimensions, Sociology, v. 4, n. 44, p. 603-622, 2010.
AMERICAN PSYCHIATRIC ASSOCIATION (APA). Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Washington: APA, 2013.
ADMINISTRACIÓN NACIONAL DE MEDICAMENTOS, ALIMENTOS Y TECNOLOGÍA MÉDICA (ANMAT).
BARKLEY, R. Attention-Deficit Hyperactivity Disorder. A handbook for diagnosis andtreatment. New York: The Guilford Press, 2006.
BELL, S.; FIGERT, A. (ed.). Reimagining (bio)medicalization, pharmaceuticals and genetics.Old critiques and new engagements. New York: Routledge, 2015.
BERGEY, M.; FILIPE, A.; CONRAD, P.; SINGH, I. (org.). Global Perspectives on ADHD: Social Dimensions of Diagnosis and Treatment in 16 Countries. Baltimore: Johns Hopkins University Press, 2018.
BIANCHI, E. ADHD y discursos de la salud sobre la infancia en el AMBA (1994-2011). Configuraciones discursivas y efectos de poder. Maestría en Investigación en Ciencias Sociales, Universidad de Buenos Aires, 2012.
BIANCHI, E. Gubernamentalidad, tecnologías y disputas. Una genealogía de los saberesprofesionales acerca del ADHD en la infancia (1994-2012). Doctorado en Ciencias Sociales, Universidad de Buenos Aires, 2014a.
BIANCHI, E. Todo tiene un principio... y en el principio fue el DSM-III. El desbloqueo epistemológico y tecnológico de la psiquiatría biológica estadounidense. Culturas Psi, n. 3, p.87-114, 2014b.
BIANCHI, E. Diagnósticos psiquiátricos infantiles, biomedicalización y DSM: ¿hacia una nueva (a)normalidad? Revista Latinoamericana de Ciencias Sociales, Niñez y Juventud, n. 14, v. 1, p.417-430, 2016.
BIANCHI, E.; FARAONE, S. El Trastorno por Déficit de Atención e Hiperactividad (TDA/H). Tecnologías, actores sociales e industria farmacéutica. Physis, v. 1, n. 25, p. 75-98, 2015.
BIANCHI, E.; FARAONE, S. Diagnósticos y fármacos en la infancia: una perspectiva analítica desde las ciencias sociales. In: FARAONE, S.; BIANCHI, E. (comp.). Medicalización, salud mental e infancias: perspectivas y debates desde las ciencias sociales. Investigaciones acerca de Argentina y el sur de América Latina. Buenos Aires: Teseo, 2018. p. 61-92.¿
BIANCHI, E.; FARAONE, S.; ORTEGA, F.; GONÇALVES, V. P.; ZORZANELLI, R. T. Controversias acerca del diagnóstico de TDAH y la prescripción de metilfenidato en los debates sobre la medicalización en Argentina y Brasil. Physis, v. 3, n. 27, p. 641-660, 2017.
BIANCHI, E.; ORTEGA, F.; FARAONE, S.; GONÇALVES, V. P.; ZORZANELLI, R. T. Medicalización más allá de los médicos. Marketing farmacéutico en torno al Trastorno por Déficit de Atención e Hiperactividad en Argentina y Brasil (1998-2014). Saúde & Sociedade, n. 25, p. 452-62, 2016.
BIANCHI, E.; FARAONE, S.; OBERTI, M.; LEONE, C. Medicalización como problema de salud internacional. La prensa escrita online sobre TDAH en Argentina (2001-2017). Astrolabio, v. 1, n. 24, p. 17-51, 2020.
BUSFIELD, J. Pills, Power, People: Sociological Understandings of the Pharmaceutical Industry, Sociology, v. 2, n. 40, p. 297-314, 2006.
CARBAJAL, M. ADD y ADHD, una mirada desde el periodismo. In: BENASAYAG, L. (comp.) ADDH. Niños con déficit de atención e hiperactividad. ¿Una patología de mercado? Una mirada alternativa con enfoque multidisciplinario. Argentina: Noveduc, 2007. p. 237-244.
CENTROS PARA EL CONTROL Y LA PREVENCIÓN DE ENFERMEDADES (CDC). Datos sobre el TDAH. 2018. Disponible en: http://www.cdc.gov/ncbddd/spanish/adhd/facts.html.
CEA D’ANCONA, M. Metodología Cuantitativa: estrategias y técnicas de investigación social. Madrid: Síntesis, 1996.
CLARKE, A. E.; SHIM, J. Medicalization and biomedicalization Revisited: technoscience and transformations of health, illness and American medicine. In: PESCOSOLIDO, B. A.; MARTIN,
J. K.; MCLEOD, J. D.; ROGERS, A. (ed.). Handbook of the sociology of health, illness, and healing. A Blueprint for the 21st Century. New York: Springer; 2011. p. 173-195.
CONRAD, P. The discovery of hyperkinesis. Notes on the medicalization of deviant behavior. Social Problems, v. 1, n. 23, p. 12-21, 1975.
CONRAD, P. Sobre la medicalización de la anormalidad y el control social. In: INGLEBY, D. (ed.). Psiquiatría Crítica. La política de la salud mental. Barcelona: Grijalbo, 1982. p. 129-154.
CONRAD. P. The shifting engines of medicalization. Journal of Health and Social Behaviour, v. 1, n. 46, p. 3-14, 2005.
CONRAD, P. Medicalization: changing contours, characteristics, and contexts. In: COCKERHAM, W. (ed.). Medical sociology on the move: new directions in theory. New York: Springer, 2013.
CONRAD, P.; BERGEY, M. The impending globalization of ADHD: Notes on the expansion and growth of a medicalized disorder. Social Science & Medicine, n. 122, p. 31-43, 2014.
CONRAD, P.; POTTER, D. From hyperactive children to ADHD adults. Observations on the expansion of medical categories. In: CONRAD, P.; LEITER, V. (ed.). Health and health care as social problems. New York: Rowman & Littlefield, 2003. p. 39-65.
CONRAD, P.; SCHNEIDER, J. W. Deviance and Medicalization. From badness to sickness. Philadelphia: Temple University, 1992.
FARAONE, S. Reformas en salud mental. Dilemas en torno a las nociones, conceptos y tipificaciones, Salud Mental y Comunidad, n. 3, p. 29-40, 2013.
FARAONE, S; BIANCHI, E. The Journey of ADHD in Argentina: From the Increase in Methylphenidate Use to Tensions among Health Professionals. In: BERGEY, M.; FILIPE, A.; CONRAD, P.; SINGH, I. (ed.). Global Perspectives on ADHD. Social Dimensions of Diagnosis and Treatment in Sixteen Countries. Baltimore: Johns Hopkins University Press, 2018. p. 162-185.
FARAONE, S.; ARIZAGA, C.; BARCALA, A.; TORRICELLI, F.; BIANCHI, E.; BALLESTEROS, I. Campo Salud. In: ARIZAGA, C.; FARAONE, S. La medicalización de la infancia. Niños, escuela y psicotrópicos. Buenos Aires, SEDRONAR–II.GG. 2008. p. 163-237.
FARAONE, S.; BIANCHI, E. (comp.). Medicalización, salud mental e infancias: perspectivas y debates desde las ciencias sociales. Investigaciones acerca de Argentina y el sur de América Latina. Buenos Aires: Teseo, 2018.
FARAONE, S. V.; SERGEANT, J.; GILLBERG, C.; BIEDERMAN, J. The worldwide prevalence of ADHD: is it an American condition? Journal of World Psychiatry, v. 2, n. 2, p. 104-113, 2003.
GREENE, J.; SISMONDO, S. (ed.). The Pharmaceutical Studies Reader. New Jersey: Wiley Blackwell, 2015.
HEALY, D. The Creation of Psychopharmacology. London: Harvard University Press, 2002.
HERNÁNDEZ SAMPIERI, R.; FERNÁNDEZ COLLADO, C.; BAPTISTA LUCIO, P. Metodología de la investigación. Mc Graw Hill: México, 1998.
JENKINS, J. Psychopharmaceutical Self and Imaginary in the social field of Phychiatric Treatment. In: JENKINS, J. (ed.). Pharmaceutical Self. The Global Shaping of Experience in an Age of Phychopharmacology. Santa Fe: SAR, 2011. p. 17-40.
JUNTA INTERNACIONAL DE FISCALIZACIÓN DE ESTUPEFACIENTES (JIFE). Informe 1995. Disponible en: http://www.incb.org/documents/Publications/AnnualReports/AR1995/AR_1995_S.pdf Acceso en: 1 jul. 2020.
JUNTA INTERNACIONAL DE FISCALIZACIÓN DE ESTUPEFACIENTES (JIFE). Informe 2006. Available from: http://www.incb.org/documents/Publications/AnnualReports/AR2006/AR_2006_Spanish.pdf. Acceso en: 1 jul. 2020.
JUNTA INTERNACIONAL DE FISCALIZACIÓN DE ESTUPEFACIENTES (JIFE). Informe 2012. Disponible en: http://www.incb.org/documents/Publications/AnnualReports/AR2012/AR_2012_S.pdf. Acceso en: 1 jul. 2020.
JUNTA INTERNACIONAL DE FISCALIZACIÓN DE ESTUPEFACIENTES (JIFE). Informe 2014. Disponible en: https://www.incb.org/documents/Publications/AnnualReports/AR2014/Spanish/AR_2014_ESP.pdf. Acceso en: 1 jul. 2020.
JUNTA INTERNACIONAL DE FISCALIZACIÓN DE ESTUPEFACIENTES (JIFE). Informe 2015. Disponible en: https://www.incb.org/documents/Publications/AnnualReports/AR2015/Spanish/AR_2015_S.pdf. Acceso en: 1 jul. 2020.
JUTEL, A. Sociology of diagnosis: a preliminary review, Sociology of Health & Illness, v. 2, n. 31, p. 278-299, 2009.
JUTEL, A. Classification, disease, and diagnosis, Perspectives in Biology and Medicine, v. 2, n. 54, p. 189-205, 2011a.
JUTEL, A. Putting a Name to it. Diagnosis in contemporary society. Baltimore: Johns Hopkins University Press, 2011b.
JUTEL, A. Beyond The Sociology of Diagnosis. Sociology Compass, v. 9, n. 9, p. 841-852, 2015.
MANIOWICZ, D. 2011. Malos diagnósticos y sobremedicación. La infancia en peligro. Revista Veintitrés, Buenos Aires, p. 27-29, 16 ju. 2011.
MAYES, R.; BAGWELL, C.; ERKULWATER, J. ADHD and the Rise in Stimulant Use Among Children. Harvard Review of Psychiatry, v. 3, n. 16, p. 151-66, 2008.
MAYES, R.; RAFALOVICH, A. Suffer the restless children: the evolution of ADHD and paediatric stimulant use, 199-80. History of Psychiatry, v. 4, n. 18, p. 435-57, 2007.
MURGUÍA, A.; ORDORIKA, T.; GUERRERO, F. Consideraciones epistemológicas en torno a la medicalización en América Latina: balances y propuestas. Ludus Vitalis, XXIV, 46, p. 99-128, 2016.
MURGUÍA, A.; ORDORIKA, T.; LENDO, L. El estudio de los procesos de medicalización en América Latina. Manguinhos Historia Ciências Saúde, v. 3, n. 23, p. 635-51, 2016.
PETRYNA, A.; LAKOFF, A.; KLEINMAN, A. (ed.). Global pharmaceuticals. Ethics, markets, practices. Durkham and London: Duke, 2006.
POLANCYK, G.; DE LIMA, M. S.; HORTA, B. L.; BIEDERMAN, J.; RODHE, L. A. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. American Journal of Psychiatry, v. 6, n. 164, p. 942-948. 2007.
REED, G.; CORREIA, J.; ESPARZA, P.; SAXENA, S.; MAJ, M. The WPA-WHO Global Survey of Psychiatrists’ Attitudes Towards Mental Disorders Classification, World Psychiatry, n. 10, p. 118-131, 2011.
ROSE, N. Psychiatry as a political science: advanced liberalism and the administration of risk, History of Human Sciences, v. 2, n. 9, p. 1-23, 1996.
ROSE, N.; ABI-RASCHED, J. Neuro: The New Brain Sciences and the Management of the Mind. Princeton-Oxford: Princeton University Press, 2013.
SHORTER, E. A Historical Dictionary of Psychiatry. New York: Oxford University Press, 2005.
SINGH, I. Beyond Polemics: Science and ethics of ADHD. Nature, v. 9, n. 12, p. 957-964, 2008.
SINGH, I.; FILIPE, A. M.; BARD, I.; BERGEY, M.; BAKER, L. Globalization and cognitive enhancement: emerging social and ethical challenges for ADHD clinicians. Current Psychiatry Reports, v. 9, n. 15, p. 385, 2013.
WHITAKER, R. Anatomia de uma epidemia. Manguinhos: Fiocruz Editora, 2017.
WILLIAMS, S.; MARTIN, P.; GABE, J. The pharmaceuticalisation of society? A framework for analysis. Sociology of Health and Illnes, v. 5, n. 33, p. 710-725. 2011.
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Política & Sociedade

This work is licensed under a Creative Commons Attribution 4.0 International License.
The articles and other work published in Política & Sociedade, a journal associated to the Graduate Program in Sociology at UFSC, are the property of the journal. A new publication of the same text, whether by the initiative of the author or third parties, must indicate that it was previously published in this journal, citing the edition and date of publication.
This work is licensed under the Creative Common License
